4096-20-2 | N-Phenylpiperidine

Packsize	Purity	Availability	Price	Discounted Price
1g	98%	in stock	$41.00	$29.00
5g	98%	in stock	$48.00	$34.00
25g	98%	in stock	$158.00	$111.00

Description

• Catalog Number: AD31250
• Chemical Name: N-Phenylpiperidine
• CAS Number: 4096-20-2
• Molecular Formula: C11H15N
• Molecular Weight: 161.2435
• MDL Number: MFCD00129777
• SMILES: C1CCN(CC1)c1ccccc1
• NSC Number: 53427

Computed Properties

• Complexity: 121
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 12
• Hydrogen Bond Acceptor Count: 1
• Rotatable Bond Count: 1
• XLogP3: 3

Literature

• Analgesics in patients with hepatic impairment: pharmacology and clinical implications.

  Drugs 20120820

• An unusual case of serotonin syndrome with oxycodone and citalopram.

  Case reports in oncological medicine 20120101

• Remifentanil alleviates transient cerebral ischemia-induced memory impairment through suppression of apoptotic neuronal cell death in gerbils.

  Korean journal of anesthesiology 20110701

• Management of an oral ingestion of transdermal fentanyl patches: a case report and literature review.

  Case reports in medicine 20110101

• A comparative study of efficacy of esmolol and fentanyl for pressure attenuation during laryngoscopy and endotracheal intubation.

  Saudi journal of anaesthesia 20110101

• Effects of casoxin 4 on morphine inhibition of small animal intestinal contractility and gut transit in the mouse.

  Clinical and experimental gastroenterology 20110101

• Comparison of Bupivacaine Alone and in Combination with Fentanyl or Pethidine for Bilateral infraorbital Nerve Block for Postoperative Analgesia in Paediatric Patients for Cleft Lip Repair: A Prospective Randomized Double Blind Study.

  Journal of anaesthesiology, clinical pharmacology 20110101

• Intrathecal sufentanil versus fentanyl for lower limb surgeries - a randomized controlled trial.

  Journal of anaesthesiology, clinical pharmacology 20110101

• Exploration of piperidine-4-yl-aminopyrimidines as HIV-1 reverse transcriptase inhibitors. N-Phenyl derivatives with broad potency against resistant mutant viruses.

  Bioorganic & medicinal chemistry letters 20101015

• (E)-3-(4-Meth-oxy-phen-yl)-1-[4-(piperidin-1-yl)phen-yl]prop-2-en-1-one.

  Acta crystallographica. Section E, Structure reports online 20100801

• Biophysical investigation of the mode of inhibition of tetramic acids, the allosteric inhibitors of undecaprenyl pyrophosphate synthase.

  Biochemistry 20100629

• SAR of N-phenyl piperidine based oral integrin alpha5beta1 antagonists.

  Bioorganic & medicinal chemistry letters 20100101

• Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease.

  Molecular neurodegeneration 20100101

• Does the use of ketamine or nitroglycerin as an adjuvant to lidocaine improve the quality of intravenous regional anesthesia?

  Saudi journal of anaesthesia 20100101

• Intrathecal sufentanil versus fentanyl for lower limb surgeries - a randomized controlled trial.

  Journal of anaesthesiology, clinical pharmacology 20100101

• Synthesis and pharmacological evaluation of new 1-[3-(4-phenylpiperazin-1-yl)-propyl]- and 1-[3-(4-phenylpiperidine)-propyl]- 3-aryl-3-alkyl-pyrrolidin-2-one derivatives with antiarrhythmic and antihypertensive activity.

  Acta poloniae pharmaceutica 20090101

• Me-talnetant and osanetant interact within overlapping but not identical binding pockets in the human tachykinin neurokinin 3 receptor transmembrane domains.

  Molecular pharmacology 20080601

• Amphetamine and pseudoephedrine cross-tolerance measured by c-Fos protein expression in brains of chronically treated rats.

  BMC neuroscience 20080101

• Synthesis and biological evaluation of phenyl piperidine derivatives as CCR2 antagonists.

  Bioorganic & medicinal chemistry letters 20071101

• 4,6-Dimethyl-2-[(4-phenylpiperidin-1-yl)methyl]isothiazolo[5,4-b]pyridin-3(2H)-one and 4,6-dimethyl-2-[(4-phenyl-1,2,3,6-tetrahydropyridin-1-yl)methyl]isothiazolo[5,4-b]pyridin-3(2H)-one.

  Acta crystallographica. Section C, Crystal structure communications 20070801

• Reversal of resistance in microorganisms by help of non-antibiotics.

  The Journal of antimicrobial chemotherapy 20070601

• Serotonin syndrome caused by interaction between citalopram and fentanyl.

  Journal of clinical pharmacy and therapeutics 20070401

• Loperamide: a pharmacological review.

  Reviews in gastroenterological disorders 20070101

• Dopamine transporter ligands: recent developments and therapeutic potential.

  Current topics in medicinal chemistry 20060101

• Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity.

  British journal of anaesthesia 20051001

• Tissue distribution of loperamide and N-desmethylloperamide following a fatal overdose.

  Journal of analytical toxicology 20051001

• Paroxetine overdose.

  Indian journal of psychiatry 20050101

• Identification of a new scaffold for opioid receptor antagonism based on the 2-amino-1,1-dimethyl-7-hydroxytetralin pharmacophore.

  Journal of medicinal chemistry 20041007

• Schizophrenia: from dopamine to glutamate and back.

  Current medicinal chemistry 20040201

• Phenylpiperidine selective serotonin reuptake inhibitors interfere with multidrug efflux pump activity in Staphylococcus aureus.

  International journal of antimicrobial agents 20030901

• NR2B selective NMDA receptor antagonists.

  Current pharmaceutical design 20020101

• Activation profiles of opioid ligands in HEK cells expressing delta opioid receptors.

  BMC neuroscience 20020101

• Novel (4-piperidin-1-yl)-phenyl sulfonamides as potent and selective human beta(3) agonists.

  Bioorganic & medicinal chemistry 20010801

• Coadministration of (-)-OSU6162 with l-DOPA normalizes preproenkephalin mRNA expression in the sensorimotor striatum of primates with unilateral 6-OHDA lesions.

  Experimental neurology 20010501

• (4-Piperidin-1-yl)phenyl amides: potent and selective human beta(3) agonists.

  Journal of medicinal chemistry 20010426

• Effects of acute and repeated treatment with a novel dopamine D2 receptor ligand on L-DOPA-induced dyskinesias in MPTP monkeys.

  European journal of pharmacology 20010202

• Paroxetine: a review.

  CNS drug reviews 20010101